MAPT and Cognitive impairment: Notably, when examining these associations in mildly symptomatic individuals further along the AD trajectory, by including carriers with subjective cognitive concerns and mild cognitive impairment, we found that the LAS-FNAME was associated with tau burden in the entorhinal and inferior temporal cortices, early sites of tau accumulation.